Literature DB >> 23881463

Identification of microRNAs associated with lymphangiogenesis in human gastric cancer.

B Yang1, C Jing, J Wang, X Guo, Y Chen, R Xu, L Peng, J Liu, L Li.   

Abstract

PURPOSE: Lymphatic metastasis is a primary cause of gastric cancer-related death, yet factors governing tumor cell lymphatic metastasis have not been fully elucidated. MicroRNAs (miRNAs) are a recently discovered class of regulatory, non-coding RNAs, some of which are involved in gastric cancer progression. However, little is known about which miRNA contributes to the lymphatic metastasis in human gastric cancer. This prompted us to find the significant miRNAs associated with lymphangiogenesis in human gastric cancer.
METHODS: We screened vascular endothelial growth factor C (VEGF-C) expression in several gastric cancer cell lines as well as in the immortalized human gastric mucosal cell line GES-1, by real-time reverse transcriptase PCR (qRT-PCR). The gastric cancer cell lines MKN-45 and SGC-7901, which have commonly been cultured with human lymphatic endothelial cells (HLECs) in vitro, promoted tube formation of HLECs following transformation with a VEGF-C expression vector. Using microarrays, we identified a panel of differentially expressed miRNAs in HLECs that had been co-cultured with VEGF-C-transformed gastric cancer cells compared with non-transformed gastric cancer cells. A subset of miRNAs was further validated using qRT-PCR.
RESULTS: We found altered expression of miRNAs in HLECs co-cultured with lymphangiogenesis-inducing VEGF-C-transformed gastric cancer cells, with 47 up-regulated and 42 down-regulated miRNAs. These findings were confirmed by qRT-PCR of selected miRNAs. Furthermore, several miRNAs were differentially expressed in patients with positive lymphatic metastasis of the primary gastric tumor. Up-regulated miRNAs included miR-648, miR-5002-3p, miR-4754, miR-4760-5p, miR-4491, miR-4252, miR-5007-3p, and miR-647; and down-regulated miRNAs included miR-3178, miR-593-5p, miR-4485, miR-135a-3p, miR-17, miR-1469, and miR-124-5p.
CONCLUSIONS: Several lymphangiogenesis-related miRNAs are significantly altered during lymphatic metastasis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881463     DOI: 10.1007/s12094-013-1081-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

Review 1.  Circulating microRNA in digestive tract cancers.

Authors:  Daisuke Ichikawa; Shuhei Komatsu; Hirotaka Konishi; Eigo Otsuji
Journal:  Gastroenterology       Date:  2012-03-17       Impact factor: 22.682

2.  Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases.

Authors:  Suvendu Das; Daniel S Ladell; Simona Podgrabinska; Vladimir Ponomarev; Chandandeep Nagi; John T Fallon; Mihaela Skobe
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  microRNA expression profile in undifferentiated gastric cancer.

Authors:  Takeyasu Katada; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitui; Yoichiro Mori; Ryo Ogawa; Koshiro Harata; Yoshitaka Fujii
Journal:  Int J Oncol       Date:  2009-02       Impact factor: 5.650

Review 4.  Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.

Authors:  Jun Wang; Yan Guo; Baocheng Wang; Jingwang Bi; Kainan Li; Xiuju Liang; Huili Chu; Huihui Jiang
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

5.  Down-regulation of VEZT gene expression in human gastric cancer involves promoter methylation and miR-43c.

Authors:  Xiaobo Guo; Changqing Jing; Leping Li; Li Zhang; Yulong Shi; Jinshen Wang; Jinglei Liu; Chensheng Li
Journal:  Biochem Biophys Res Commun       Date:  2010-12-13       Impact factor: 3.575

6.  Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer.

Authors:  Kenji Shimizu; Hajime Kubo; Koji Yamaguchi; Kazuhiko Kawashima; Yoshihide Ueda; Koichi Matsuo; Masaaki Awane; Yasuyuki Shimahara; Arimichi Takabayashi; Yoshio Yamaoka; Seiji Satoh
Journal:  Cancer Sci       Date:  2004-04       Impact factor: 6.716

7.  Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer.

Authors:  Ming-Xu Da; Xiao-Ting Wu; Jie Wang; Tian-Kang Guo; Zi-Gang Zhao; Ting Luo; Ming-Ming Zhang; Kun Qian
Journal:  Arch Med Res       Date:  2007-10-24       Impact factor: 2.235

8.  Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.

Authors:  Caname Iwata; Mitsunobu R Kano; Akiyoshi Komuro; Masako Oka; Kunihiko Kiyono; Erik Johansson; Yasuyuki Morishita; Masakazu Yashiro; Kosei Hirakawa; Michio Kaminishi; Kohei Miyazono
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

9.  Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.

Authors:  Ying-Chun Zhao; Xiao-Jian Ni; Ming-Hai Wang; Xiao-Ming Zha; Yi Zhao; Shui Wang
Journal:  Med Oncol       Date:  2012-05-06       Impact factor: 3.064

10.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

View more
  39 in total

1.  Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer.

Authors:  Li Liu; Jia-Xiang Ye; Yu-Zhou Qin; Qi-Huang Chen; Lian-Ying Ge
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.

Authors:  Ming-Ru Chiang; Chi-Wen Kuo; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo; Meng-Yao Lu; Yen-Chein Lai
Journal:  Pathol Oncol Res       Date:  2019-01-23       Impact factor: 3.201

3.  MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.

Authors:  Zhen Yang; Ruoming Wang; Tengteng Zhang; Xinhua Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Decreased expression of serum miR-647 is associated with poor prognosis in gastric cancer.

Authors:  Huan Ma; Peijun Wang; Yuan Li; Yan Yang; Shuhui Zhan; Yuqiang Gao
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

5.  Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.

Authors:  Yong-Bin Zheng; Gao-Chun Xiao; Shi-Lun Tong; Yu Ding; Qiu-Shuang Wang; Sheng-Bo Li; Zhi-Nan Hao
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

6.  Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer.

Authors:  Jin Liu; Chuifang Wang; Xiangyan Liu; Yu Wang; Haibo Liu; Guohua Ren; Liangming Zhu; Zhigang Sun; Zhitao Chen
Journal:  Oncol Lett       Date:  2017-03-30       Impact factor: 2.967

7.  MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1.

Authors:  X Han; Y Chen; N Yao; H Liu; Z Wang
Journal:  Cancer Gene Ther       Date:  2015-01-23       Impact factor: 5.987

8.  The up-regulation of miR-300 in gastric cancer and its effects on cells malignancy.

Authors:  Zhen Shen; Chunsheng Li; Kai Zhang; Wei Yu; Huijie Xiao; Bo Li; Tongjun Liu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Nucleostemin regulates proliferation and migration of gastric cancer and correlates with its malignancy.

Authors:  Hongxue Wu; Weixing Wang; Shilun Tong; Chong Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1.

Authors:  Haoning Fan; Meng Shao; Shaohui Huang; Ying Liu; Jie Liu; Zhiyuan Wang; Jianxin Diao; Yuanliang Liu; L I Tong; Qin Fan
Journal:  Oncol Lett       Date:  2016-04-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.